| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Board of Directors | CEO +3 more
2 companies
Abdun-Nabi Daniel serves as a CEO at EBS and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 20 sells. Those positions are worth an estimated $8.3M at current prices.
The biggest single holding is EBS (~$8.3M) as CEO. The recent filings there lean toward selling, a net 371,630 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2017 | EBS Emergent Biosolutions Inc. | President and CEO | Sale+OE | 28,240 | $31.28 | $883,296.37 | -13.0% | |
| Jun 1, 2016 | EBS Emergent Biosolutions Inc. | President &CEO | Sell | 8,699 | $43.74 | $380,494.26 | -4.8% | |
| May 20, 2016 | EBS Emergent Biosolutions Inc. | President &CEO | Sell | 8,701 | $42.00 | $365,442.00 | -4.6% | |
| Apr 18, 2016 | EBS Emergent Biosolutions Inc. | President &CEO | Sell | 8,702 | $40.17 | $349,559.34 | -4.4% | |
| Dec 24, 2015 | EBS Emergent Biosolutions Inc. | President &CEO | Sale+OE | 63,209 | $39.06 | $2,468,632.81 | -25.4% |